Search details
1.
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
Histopathology
; 82(5): 722-730, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36583256
2.
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.
Pathobiology
; 90(3): 166-175, 2023.
Article
in English
| MEDLINE | ID: mdl-36202073
3.
European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Int J Mol Sci
; 24(18)2023 Sep 07.
Article
in English
| MEDLINE | ID: mdl-37762091
4.
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
J Pathol
; 250(1): 19-29, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31471895
5.
[Current methods in molecular pathology]. / Aktuelle molekularpathologische Methoden.
Ther Umsch
; 76(4): 173-178, 2019 Sep.
Article
in German
| MEDLINE | ID: mdl-31498035
6.
Short sequences can efficiently recruit histone H3 lysine 27 trimethylation in the absence of enhancer activity and DNA methylation.
Proc Natl Acad Sci U S A
; 111(33): E3415-21, 2014 Aug 19.
Article
in English
| MEDLINE | ID: mdl-25092339
7.
Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer.
J Clin Med
; 12(6)2023 Mar 17.
Article
in English
| MEDLINE | ID: mdl-36983354
8.
Preanalytical Variables and Sample Quality Control for Clinical Variant Analysis.
Methods Mol Biol
; 2493: 331-351, 2022.
Article
in English
| MEDLINE | ID: mdl-35751825
9.
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALL.
EJHaem
; 3(3): 1009-1012, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-36051082
10.
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.
Lung Cancer
; 172: 154-159, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36099710
11.
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.
Sci Rep
; 12(1): 1342, 2022 01 25.
Article
in English
| MEDLINE | ID: mdl-35079117
12.
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology Consortium.
J Mol Diagn
; 23(7): 882-893, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33964449
13.
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients.
Lung Cancer
; 149: 84-89, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32980613
14.
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
J Mol Diagn
; 21(5): 884-894, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31229654
15.
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Cell Death Dis
; 10(7): 534, 2019 07 11.
Article
in English
| MEDLINE | ID: mdl-31296838
16.
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer.
Clin Cancer Res
; 25(10): 3026-3034, 2019 05 15.
Article
in English
| MEDLINE | ID: mdl-30765392
17.
Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry staining.
Oral Oncol
; 146: 106542, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37619521
18.
A scalable solution for tumor mutational burden from formalin-fixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay.
Transl Lung Cancer Res
; 7(6): 616-630, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30505706
Results
1 -
18
de 18
1
Next >
>>